July 15, 2025 a 11:43 am

BAX: Fundamental Ratio Analysis - Baxter International Inc.

Baxter International Inc. Stock Analysis

Baxter International Inc. operates within a robust healthcare market, providing essential medical products and services globally. The company maintains a strong presence with its diversified product portfolio and widespread distribution. However, their financial performance reflects moderate scores, indicating certain areas of concern.

Fundamental Rating

Baxter International's fundamental scores reveal a moderate financial standing and some areas for improvement, specifically in equity and asset returns.

Category Score
Discounted Cash Flow 4
Return on Equity 1
Return on Assets 1
Debt to Equity 1
Price to Earnings 1
Price to Book 3

Historical Rating

The historical data reflects changes in the financial health of Baxter, with a consistent performance in certain critical areas but an overall improvement in the total score.

Date Overall Score DCF ROE ROA Debt to Equity P/E P/B
2025-07-14 2 4 1 1 1 1 3
-- 0 4 1 1 1 1 3

Analyst Price Targets

Analysts provide a spectrum of price targets that underscore a moderately bearish consensus on Baxter's near-term growth potential.

High Low Median Consensus
$98 $30 $44.5 $59.07
Stock Chart for Baxter International Inc.

Analyst Sentiment

The analyst sentiment indicates a prevailing 'Hold' position, with a predominant lean towards maintaining shares rather than aggressive buying or selling.

Recommendation Count
Strong Buy 0
Buy 16
Hold 19
Sell 1
Strong Sell 0

Conclusion

Baxter International Inc. remains a stable player in the healthcare sector but currently exhibits mixed financial results. With the stock being mostly held rather than actively traded, investors are advised to cautiously watch market signals and evaluate risks tied to its modest financial scores. Baxter's diverse healthcare solutions provide a solid foundation despite its financial challenges, potentially positioning it for future growth.